Information  X 
Enter a valid email address

Astrazeneca PLC OrdShs USD0.25 (AZN)

Related News

13-Sep-2019 10:10 AM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8200p (from 8000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
11-Sep-2019 08:10 AM

Broker Forecast - Citigroup issues a broker note on AstraZeneca PLC

Citigroup today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 10000p (from 7000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
09-Sep-2019 09:50 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7800p (from 7600p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
06-Sep-2019 12:40 PM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8000p (from 7800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
02-Sep-2019 08:40 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7600p (from 7200p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
16-Aug-2019 08:30 AM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7800p (from 7600p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
14-Aug-2019 09:40 AM

Broker Forecast - UBS issues a broker note on AstraZeneca PLC

UBS today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 5700p (from 5400p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
06-Aug-2019 09:10 AM

Broker Forecast - Goldman Sachs issues a broker note on AstraZeneca PLC

Goldman Sachs today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 5500p (from 5000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
29-Jul-2019 08:30 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7200p (from 6900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
26-Jul-2019 09:50 AM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7600p (from 7500p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
25-Jul-2019 07:31 AM

AstraZeneca lifts product sales guidance amid stronger H1

AstraZeneca upgraded its product sales guidance as an acceleration in second-quarter sales bolstered its first-half performance. Product sales in 2019 were now expected to increase by a low double-digit percentage; the prior guidance was for a high sin
08-Jul-2019 09:10 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 6900p (from 6800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
24-May-2019 09:10 AM

Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC

Jefferies International today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 6350p (from 6400p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
24-May-2019 09:00 AM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7200p (from 7000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
10-May-2019 08:10 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 6800p (from 6900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
02-May-2019 10:50 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 6900p (from 6800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
30-Apr-2019 10:30 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 6800p (from 6900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
26-Apr-2019 07:33 AM

AstraZeneca more than doubles profits in Q1 as newer cancer drugs boost growth

AstraZeneca more than doubled pre-tax profits in the first quarter of the year as the continued success of its new medicines and emerging markets performance boosted product sales. For the 3 months to 31 March, pre-tax profits rose to $758m from $374m
05-Apr-2019 08:50 AM

Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC

Liberum Capital today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 6400p (from 5800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
02-Apr-2019 11:20 AM

Broker Forecast - HSBC issues a broker note on AstraZeneca PLC

HSBC today reaffirms its reduce investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 5180p (from 5140p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
02-Apr-2019 09:50 AM

Broker Forecast - UBS issues a broker note on AstraZeneca PLC

UBS today downgrades its investment rating on AstraZeneca PLC (LON:AZN) to sell (from neutral) and cut its price target to 5400p (from 5900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
01-Apr-2019 11:00 AM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7000p (from 6800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
12-Mar-2019 01:10 PM

Broker Forecast - Goldman Sachs issues a broker note on AstraZeneca PLC

Goldman Sachs today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 5000p (from 4080p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
22-Feb-2019 10:50 AM

Broker Forecast - Bryan Garnier issues a broker note on AstraZeneca PLC

Bryan Garnier today downgrades its investment rating on AstraZeneca PLC (LON:AZN) to neutral (from neutral). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
14-Feb-2019 07:28 AM

AstraZeneca meets guidance as strong performance of new medicines deliver boost

AstraZeneca said Thursday a 'strong' fourth quarter led by performance of new medicines underscored its return to growth as the drugmaker met its guidance. For the 12 months to 31 December, revenue fell 2% to $22.1bn and product sales rose 4%
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t